Genome editing specialist Cellectis has kicked off clinical tests in the US for the very first of-the-shelf...
Up To Date
Latest News
European venture capitalist Seventure Partners and Johnson & Johnson have invested US$12m in Israel-based...
Venture Capitalist Biogeneration Ventures has exceeded the target size of its life sciences fund BGV III...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended two...
A publication in Science Translational Medicine shows that Roche has a rising star in the 15 million patient...
German oncologists have unveiled that market-approved inhibitors of DNA methyltransferases (DMNTi) and...